Company Filing History:
Years Active: 2019
Title: Wei-Chen Wang: Innovator in Viral Detection Methods
Introduction
Wei-Chen Wang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of viral detection, particularly in the detection of canine parvovirus (CPV). His innovative methods have the potential to enhance diagnostic accuracy and improve veterinary care.
Latest Patents
Wei-Chen Wang holds a patent for a method for detection of CPV 2a, 2b, and 2c, as well as for discriminating wild type from vaccine type. The patent describes a technique that involves detecting the VP2 gene in a sample. The signals can be identified using both a fluorescent detection system and a lateral flow immunochromatographic assay. Additionally, the invention provides methods to differentiate between wild type and vaccine type using specific single nucleotide polymorphisms (SNPs).
Career Highlights
Wei-Chen Wang is associated with Credo Biomedical Pte Ltd., where he applies his expertise in viral detection. His work has been instrumental in advancing diagnostic methods in the field of veterinary medicine. He has demonstrated a commitment to innovation and research, contributing to the development of effective detection techniques.
Collaborations
Wei-Chen Wang collaborates with notable colleagues, including Jr Winston Wong and Stephen Chang-Chi Kao. Their combined efforts in research and development have fostered advancements in the detection of viral pathogens.
Conclusion
Wei-Chen Wang's contributions to the field of viral detection exemplify the impact of innovative thinking in veterinary diagnostics. His patented methods represent a significant step forward in ensuring accurate detection and differentiation of viral strains.